DCBAD-2303

N/A

Report date: 2026/04/24 20:01:59

First In Class

Base Information

Drug NameDCBAD-2303

Drug Alias NameDCBAD2303DCBAD-2303

ClassificationBiologics > Protein drugs > Immunoglobulin > Antibody > Antibody conjugate > Antibody drug conjugate (ADC)Biologics > Protein drugs > Immunoglobulin > Antibody > Antibody conjugate > Antibody drug conjugate (ADC) > Payload > MMAE payloadBiologics > Protein drugs > Immunoglobulin > Antibody > Antibody conjugate > Antibody drug conjugate (ADC) > Linker > Cleavable linker > VC linker

Mechanisms of ActionAnti-CD276Tubulin inhibitors

TargetsCD276 antigenTubulin

Therapy Area/IndicationsNeoplasms

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritoryTaiwan

CombinationsNo

Global Highest StatusPreclinical

Highest Status in ChinaN/A

Originator CompaniesDevelopment Center for Biotechnology

China Registration ClassN/A

Develop Information

Active CompaniesDevelopment Center for Biotechnology

Inactive CompaniesN/A

Active IndicationsNeoplasms

Inactive IndicationsN/A

Other Information

ATC CodeN/A